Analyzing Henry Schein (NASDAQ:HSIC) and Green Cures & Botanical Distribution (OTCMKTS:GRCU)

Green Cures & Botanical Distribution (OTCMKTS:GRCU) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership.

Earnings and Valuation

This table compares Green Cures & Botanical Distribution and Henry Schein”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Green Cures & Botanical Distribution	N/A	N/A	N/A	N/A	N/A
Henry Schein	$12.94 billion	0.67	$390.00 million	$3.16	22.75

Henry Schein has higher revenue and earnings than Green Cures & Botanical Distribution.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Green Cures & Botanical Distribution and Henry Schein, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Green Cures & Botanical Distribution	0	0	0	0	0.00
Henry Schein	1	8	5	0	2.29

Henry Schein has a consensus target price of $76.08, suggesting a potential upside of 5.81%. Given Henry Schein’s stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Green Cures & Botanical Distribution.

Insider & Institutional Ownership

96.6% of Henry Schein shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Green Cures & Botanical Distribution has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.

Profitability

This table compares Green Cures & Botanical Distribution and Henry Schein’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Green Cures & Botanical Distribution	N/A	N/A	N/A
Henry Schein	3.05%	14.36%	5.52%

Summary

Henry Schein beats Green Cures & Botanical Distribution on 10 of the 10 factors compared between the two stocks.

About Green Cures & Botanical Distribution

Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.